Use of antimicrobial agents for upper respiratory tract infections in Taiwanese children

Yu-Hsuan Huang1, Yhu-Chering Huang

  • 1Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Children's Hospital, Taipei.

Insights

Antibiotic misuse for pediatric upper respiratory tract infections (URTIs) fuels bacterial resistance and incurs significant costs. Judicious antimicrobial use for common URTIs is recommended to combat this public health issue.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Public health microbiology

Background:

  • Upper respiratory tract infections (URTIs) are predominantly viral, yet antibiotic misuse is prevalent in pediatric care.
  • This overuse contributes to the selection of resistant bacterial strains, including Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Moraxella catarrhalis.
  • Antibiotic resistance poses a significant public health threat, exacerbated by the frequent outpatient management of common pediatric URTIs.

Purpose of the Study:

  • To recommend judicious antimicrobial agent use for seven common pediatric URTIs.
  • To provide evidence-based guidance for healthcare practitioners in Taiwan.
  • To reduce antibiotic overuse and mitigate the growing problem of antimicrobial resistance.

Main Methods:

  • Review of local epidemiological data on pediatric URTIs.
  • Consultation of guidelines from the Infectious Disease Society of Taiwan and the American Academy of Pediatrics.
  • Development of recommendations for appropriate antimicrobial prescribing.

Main Results:

  • Identification of seven common pediatric URTIs frequently managed in outpatient settings.
  • Emphasis on differentiating viral from bacterial infections to guide antibiotic decisions.
  • Highlighting the economic burden associated with antibiotic misuse in Taiwan.

Conclusions:

  • Judicious antimicrobial prescribing for pediatric URTIs is essential to curb antibiotic resistance.
  • Education and behavior modification for practitioners are key to reducing antibiotic overuse.
  • Implementing evidence-based recommendations can help achieve the goal of reduced antimicrobial resistance.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...